Charles River Laboratories (CRL) — Capital Reinvestment Ratio
Charles River Laboratories (CRL) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow ($213.83 Million) in capital expenditures ($35.58 Million). See Charles River Laboratories (CRL) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Charles River Laboratories Capital Reinvestment Ratio (1998–2024)
This chart tracks Charles River Laboratories's Capital Reinvestment Ratio across 27 annual periods. Check how aggressively does Charles River Laboratories reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Charles River Laboratories (1998–2024)
Year-by-year Capital Reinvestment Ratio for Charles River Laboratories from 1998 to 2024. For live market cap and broader valuation context, see Charles River Laboratories market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | $734.58 Million | $232.97 Million | ▼ -31.9% |
| 2023 | 0.47x | $683.90 Million | $318.53 Million | ▼ -11.1% |
| 2022 | 0.52x | $619.64 Million | $324.73 Million | ▲ +74.3% |
| 2021 | 0.30x | $760.80 Million | $228.77 Million | ▼ -1.3% |
| 2020 | 0.30x | $546.58 Million | $166.56 Million | ▲ +4.3% |
| 2019 | 0.29x | $480.94 Million | $140.51 Million | ▼ -8.0% |
| 2018 | 0.32x | $441.14 Million | $140.05 Million | ▲ +21.8% |
| 2017 | 0.26x | $316.26 Million | $82.43 Million | ▲ +40.6% |
| 2016 | 0.19x | $298.32 Million | $55.29 Million | ▼ -16.1% |
| 2015 | 0.22x | $286.36 Million | $63.25 Million | ▼ -2.6% |
| 2014 | 0.23x | $251.05 Million | $56.92 Million | ▲ +20.0% |
| 2013 | 0.19x | $207.14 Million | $39.15 Million | ▼ -17.3% |
| 2012 | 0.23x | $207.90 Million | $47.53 Million | ▼ -4.5% |
| 2011 | 0.24x | $205.28 Million | $49.14 Million | ▼ -5.6% |
| 2010 | 0.25x | $169.01 Million | $42.86 Million | ▼ -28.7% |
| 2009 | 0.36x | $225.04 Million | $80.01 Million | ▼ -49.5% |
| 2008 | 0.70x | $279.95 Million | $197.08 Million | ▼ -11.9% |
| 2007 | 0.80x | $284.25 Million | $227.04 Million | ▼ -27.8% |
| 2006 | 1.11x | $164.37 Million | $181.75 Million | ▲ +173.9% |
| 2005 | 0.40x | $236.70 Million | $95.55 Million | ▲ +64.6% |
| 2004 | 0.25x | $184.83 Million | $45.34 Million | ▼ -7.2% |
| 2003 | 0.26x | $123.77 Million | $32.70 Million | ▼ -5.9% |
| 2002 | 0.28x | $133.66 Million | $37.54 Million | ▼ -45.4% |
| 2001 | 0.51x | $71.30 Million | $36.66 Million | ▲ +11.5% |
| 2000 | 0.46x | $33.77 Million | $15.56 Million | ▲ +33.7% |
| 1999 | 0.34x | $37.57 Million | $12.95 Million | ▲ +8.2% |
| 1998 | 0.32x | $37.38 Million | $11.91 Million | — |